Brain metastases: Gamma knife and new treatments

Essential regional control of skin cancers

Update in anti-CTLA4 and anti-PD1 treatment in advanced melanoma

New insights in Merkel cell biology and treatment

Duration of checkpoint inhibitor therapy

PD1/ CTLA4 : Upfront or sequentially?

Genetic determinants of breast cancer immune phenotypes

IMPAKT conference highlights

Deciphering the connection of genetics, immune infiltration and prognosis

Novel bi-specific TCR-based reagents for targeted cancer immunotherapy

Hallmarks of cancer cell development

Pembrolizumab and indoximod for melanoma